Natco Seeks To Trigger India CL Law By Asking Pfizer To OK HIV Copy
This article was originally published in PharmAsia News
Executive Summary
India's Natco Pharma says it has asked U.S.-based Pfizer for permission to make and sell a generic version of its HIV drug, triggering a compulsory licensing law